Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMGN $7.43 1.2300 +19.84%
STML $15.77 0.7800 +5.20%
CBMG $16.50 0.6800 +4.30%
RDUS $49.00 1.8800 +3.99%
XLRN $40.70 1.3900 +3.54%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CVM $0.69 -0.0298 -4.14%
EXEL $1.90 -0.0700 -3.55%
TLOG $4.88 -0.1200 -2.40%
ABBV $61.67 -1.4550 -2.31%
BDSI $13.33 -0.3000 -2.20%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

BMS' Opdivo Set For Early Access in UK

(PMLiVE) Jan 8, 2015 - Bristol-Myers Squibb could see an early launch of its new melanoma therapy Opdivo in the UK after becoming the first drug of its class given a new fast-track status by the country's drugs regulator.
read article 



Helsinn and Pharmacosmos Enter Into an Exclusive License Agreement For the Development and Commercialization of Monofer® in US

(CNBC) Jan 8, 2015 - Helsinn Group and Pharmacosmos A/S today jointly announce that they have entered into an agreement for the exclusive US commercialization rights to Monofer®, an innovative intravenous iron replacement therapy under development for the treatment of Iron Deficiency Anemia.
read article 



Drug Sponsors Challenged to Contain Health Care Costs While Boosting Productivity

(Tufts CSDD) Jan 8, 2015 - Drug developers will implement strategies over the next year to improve clinical study performance to help control R&D costs and boost overall productivity, while increasing their focus on the development of cost-effective therapies that can help lower health care spending, according to the Tufts Center for the Study of Drug Development.
read press release 



Roche Says U.S. Regulators Approve Blood Test For Three Viruses

(Reuters) Jan 9, 2015 - Swiss drugmaker Roche said on Friday U.S. regulators had approved its blood test for detecting the Human Immunodeficiency Virus (HIV) and the Hepatitis B and C Viruses (HBV, HCV) in donated blood products.
read article 



Sanofi, Regeneron Cholesterol Drug Also Effective in Monthly Doses

(Reuters) Jan 9, 2015 - An experimental drug from Sanofi SA and Regeneron Pharmaceuticals was found to be effective in lowering "bad" cholesterol even when administered once every four weeks, instead of every two weeks.
read article 



FDA Approves New Oral Anticoagulant From Daiichi Sankyo

(Forbes) Jan 8, 2015 - Late Thursday the FDA announced that it had approved edoxaban, the new oral anticoagulant manufactured by Daiichi Sankyo.
read article 



Senators Re-Introduce Bill to Allow Imported Medicines From Canada

(Wall Street Journal/Pharmalot blog) Jan 9, 2015 - In their latest bid to lower prescription drug costs, two U.S. Senators have re-introduced legislation that would allow Americans to purchase medicines from Canada.
read article (paid subscription required) 



Court Denies Teen’s Wish to Refuse Cancer Treatment

(TIME) Jan 8, 2015 - A 17-year-old cancer patient does not have the right to refuse treatment for her disease, the state of Connecticut’s highest court has ruled.
read article 



Physician at the Stephenson Cancer Center Named Co-Principal Investigator For the NCI's Community Oncology Research Program

(Stephenson) Jan 7, 2015 - A gynecologic oncologist at the Stephenson Cancer Center, Joan Walker, M.D., has been named a co-principal investigator for one of seven research bases in the National Cancer Institute’s (NCI) new Community Oncology Research Program (NCORP).
read press release 



Improving Care in Gastric and GE Junction Cancers

(ACCCBuzz) Jan 8, 2015 - ACCC’s Improving Quality Care in Gastric/GE Junction Cancers project seeks to better the quality of care for gastric and GE junction cancer patients treated at community cancer programs.
read article 



Medicare Begins Paying For Chronic Care Management

(ASH) Jan 8, 2015 - On January 1, 2015, the Medicare program took a significant step towards recognizing that the role of a physician goes well beyond time in the exam room.
read article 



ASCO Submits Comments to Congress on FDA’s Proposed Regulation of Laboratory-Developed Tests

(ASCO in Action) Jan 8, 2015 - ASCO submitted comments Jan. 5 to the House Committee on Energy and Commerce, Health Subcommittee, strongly supporting the Food and Drug Administration’s proposed risk-based approach to regulation of laboratory developed tests (LDTs).
read article 



Incyte, Agenus Launch Up-to-$410M-Plus Cancer Immunotherapy Collaboration

(Genetic Engineering & Biotechnology News) Jan 9, 2015 - Incyte and Agenus said today they will develop and commercialize cancer immunotherapeutics by using the latter’s Retrocyte Display™ antibody discovery platform.
read article 



'Last Hope' Drug For Prostate Cancer Patients Is Axed From the NHS, in a Move Doctors Call a 'Travesty'

(The Daily Mail [UK]) Jan 9, 2015 - A ‘last ditch’ drug for prostate cancer sufferers is to be axed from NHS use.
read article 



North Texas ACO Reaches Deal With Oncology Practice

(D Healthcare Daily) Jan 8, 2015 - The Premier Patient Health Care accountable care organization has a new preferred provider of oncology services.
read article 



Moffitt Researchers Discover Mechanism Leading to Drug Resistance, Metastasis in Melanoma Patients

(Moffitt) Jan 6, 2015 - Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it.
read press release 



In Head and Neck Cancer, Surgeons Need Solid Answers About Tumor Recurrence

(Dartmouth-Hitchcock/Norris CCC) Jan 8, 2015 - Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues.
read press release 



Hope For Breast Cancer Patients as Scientists Discover What Triggers Aggressive Form of the Disease

(Daily Mail [UK]) Jan 9, 2015 - Scientists have discovered what triggers one of the most deadly types of breast cancer, raising hopes of new treatments for it.
read article 



Distant Family History an Effective Predictor of Prostate Cancer, Study Says

(FoxNews.com) Jan 8, 2015 - Prostate cancer incidence among distant relatives on both sides of a man’s family can help predict whether he will develop the disease, suggests a new study published in the journal Prostate.
read article 



Oral Human Papillomavirus Infection More Likely to Persist in Older Men

(AACR) Jan 9, 2015 - Oral infection with human papillomavirus 16 (HPV16), which is the type of HPV most frequently linked to HPV-driven head and neck cancers, was more likely to persist 12 or more months in men older than 45 than in those younger than 45, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
read press release 



What the FDA Panel Vote on a Biosimilar Says About Approvals

(Wall Street Journal/Pharmalot blog) Jan 8, 2015 - The unanimous vote yesterday by an FDA advisory panel to recommend the agency approve a biosimilar version of an Amgen drug known as Neupogen was a landmark decision.
read article (paid subscription required) 



Aveo Replaces CEO Ha-Ngoc, Lays Off Most of Remaining Employees

(Boston Business Journal/BioFlash blog) Jan 7, 2015 - The management of the Cambridge cancer drug developer has long been criticized for the 2013 failure of its lead drug to get FDA approval.
read article 



Appeals Court Leaves Intact Alzheimer's Drug Order

(Charlotte Observer/Associated Press) Jan 7, 2015 - A federal appeals court has left intact a judge's order for drug manufacturer Actavis PLC to keep distributing its widely used Alzheimer's medication.
read article 



Novartis Applies For U.S. Approval For Lung Disease Drugs

(NASDAQ/Dow Jones Business News) Jan 8, 2015 - Novartis AG said it has filed for U.S. regulatory approval of two drugs that treat chronic lung diseases after late-stage clinical tests demonstrated the treatments met their primary goals.
read article 



Ahead of the Bell: Infinity Pharmaceuticals Shares Slide

(BloombergBusinessweek/Associated Press) Jan 8, 2015 - Infinity Pharmaceuticals will stop studying one of its potential drugs as a rheumatoid arthritis treatment after it failed to generate enough improvement in patients during a mid-stage study.
read article